|
|
| | Clindamycin 3-Phosphate Basic information |
| Product Name: | Clindamycin 3-Phosphate | | Synonyms: | Clindamycin 3-Phosphate;ClindaMycin 3-Phosphate
DISCONTINUED;Clindamycin Phosphate EP IMP C;(2R,3S,4S,5R,6R)-2-((1S,2S);Clindamycin Phosphate EP Impurity C/Clindamycin 3-Phosphate/(2R,3S,4S,5R,6R)-2-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-3,5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-4-yl dihydrogen phosphate;Clindamycin phosphate Impurity C(Clindamycin 3-Phosphatediscontinued);(2R,3S,4S,5R,6R)-2-((2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-3,5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-4-yl dihydrogen phosphate;Clindamycin Impurity 12(Clindamycin Phosphate EP Impurity C) | | CAS: | 28708-34-1 | | MF: | C18H34ClN2O8PS | | MW: | 504.96 | | EINECS: | | | Product Categories: | Carbohydrates & Derivatives;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Phosphorylating and Phosphitylating Agents | | Mol File: | 28708-34-1.mol |  |
| | Clindamycin 3-Phosphate Chemical Properties |
| density | 1.41±0.1 g/cm3(Predicted) | | pka | 1.85±0.10(Predicted) |
| | Clindamycin 3-Phosphate Usage And Synthesis |
| Uses | Clindamycin (C580000) impurity. |
| | Clindamycin 3-Phosphate Preparation Products And Raw materials |
|